359 related articles for article (PubMed ID: 27443134)
1. World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.
Prins KW; Thenappan T
Cardiol Clin; 2016 Aug; 34(3):363-74. PubMed ID: 27443134
[TBL] [Abstract][Full Text] [Related]
2. Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V.
Bhogal S; Mukherjee D; Banerjee S; Islam AM; Daggubati R; Paul TK
Curr Probl Cardiol; 2018 May; 43(5):217-231. PubMed ID: 29153390
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function.
Badagliacca R; Poscia R; Pezzuto B; Papa S; Gambardella C; Francone M; Mezzapesa M; Nocioni M; Nona A; Rosati R; Sciomer S; Fedele F; Dario Vizza C
J Heart Lung Transplant; 2015 Mar; 34(3):381-9. PubMed ID: 25087105
[TBL] [Abstract][Full Text] [Related]
4. Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.
Clark CB; Horn EM
Cardiol Clin; 2016 Aug; 34(3):401-11. PubMed ID: 27443137
[TBL] [Abstract][Full Text] [Related]
5. Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology.
Badagliacca R; Poscia R; Pezzuto B; Nocioni M; Mezzapesa M; Francone M; Giannetta E; Papa S; Gambardella C; Sciomer S; Volterrani M; Fedele F; Dario Vizza C
J Heart Lung Transplant; 2015 Mar; 34(3):395-403. PubMed ID: 25499139
[TBL] [Abstract][Full Text] [Related]
6. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Frost AE; Badesch DB; Barst RJ; Benza RL; Elliott CG; Farber HW; Krichman A; Liou TG; Raskob GE; Wason P; Feldkircher K; Turner M; McGoon MD
Chest; 2011 Jan; 139(1):128-37. PubMed ID: 20558556
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure.
Saouti N; Westerhof N; Helderman F; Marcus JT; Boonstra A; Postmus PE; Vonk-Noordegraaf A
Am J Respir Crit Care Med; 2010 Nov; 182(10):1315-20. PubMed ID: 20622041
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
Badesch DB; Raskob GE; Elliott CG; Krichman AM; Farber HW; Frost AE; Barst RJ; Benza RL; Liou TG; Turner M; Giles S; Feldkircher K; Miller DP; McGoon MD
Chest; 2010 Feb; 137(2):376-87. PubMed ID: 19837821
[TBL] [Abstract][Full Text] [Related]
9. Special Situations in Pulmonary Hypertension: Pregnancy and Right Ventricular Failure.
Svetlichnaya J; Janmohammed M; De Marco T
Cardiol Clin; 2016 Aug; 34(3):473-87. PubMed ID: 27443142
[TBL] [Abstract][Full Text] [Related]
10. Cor triatriatum: a reversible cause of severe pulmonary hypertension.
Howe MJ; Thomas MP; Agarwal PP; Bach DS; Rubenfire M
Can J Cardiol; 2015 Apr; 31(4):548.e1-3. PubMed ID: 25745881
[TBL] [Abstract][Full Text] [Related]
11. Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments.
Klinger JR
Cardiol Clin; 2016 Aug; 34(3):413-33. PubMed ID: 27443138
[TBL] [Abstract][Full Text] [Related]
12. Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.
Vicenzi M; Deboeck G; Faoro V; Loison J; Vachiery JL; Naeije R
Int J Cardiol; 2016 Jan; 202():736-40. PubMed ID: 26469553
[TBL] [Abstract][Full Text] [Related]
13. Current pathophysiological concepts and management of pulmonary hypertension.
Lourenço AP; Fontoura D; Henriques-Coelho T; Leite-Moreira AF
Int J Cardiol; 2012 Mar; 155(3):350-61. PubMed ID: 21641060
[TBL] [Abstract][Full Text] [Related]
14. Current therapeutics and practical management strategies for pulmonary arterial hypertension.
Agarwal R; Gomberg-Maitland M
Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279
[TBL] [Abstract][Full Text] [Related]
15. High altitude pulmonary hypertension with severe right ventricular dysfunction.
Maripov A; Mamazhakypov A; Karagulova G; Sydykov A; Sarybaev A
Int J Cardiol; 2013 Oct; 168(3):e89-90. PubMed ID: 23911270
[No Abstract] [Full Text] [Related]
16. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive indices of right ventricular function are markers of ventricular-arterial coupling rather than ventricular contractility: insights from a porcine model of chronic pressure overload.
Guihaire J; Haddad F; Boulate D; Decante B; Denault AY; Wu J; Hervé P; Humbert M; Dartevelle P; Verhoye JP; Mercier O; Fadel E
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1140-9. PubMed ID: 23677917
[TBL] [Abstract][Full Text] [Related]
18. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.
Chin KM; Kingman M; de Lemos JA; Warner JJ; Reimold S; Peshock R; Torres F
Am J Cardiol; 2008 Jun; 101(11):1669-72. PubMed ID: 18489949
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based approach to screening and diagnosis of pulmonary hypertension.
Haddad RN; Mielniczuk LM
Can J Cardiol; 2015 Apr; 31(4):382-90. PubMed ID: 25840091
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
